biovisionK849-100CYP2C inhibitor screening kit, CYP2C19 inhibitor kit, CYP inhibitor screening, screen cytochrome P450 inhibitors, study Cytochrome P450 2C19 inhibitors, characterize CYP inhibitors, characterize CYP ligands, CYP2C19 inhibitor, CYP2C inhibitor screening kit, cyp2c inhibitor kit, cytochrome inhibitor screening, screen cyp2c inhibitors, screen cyp2c ligands, screen CYP2C19 inhibitors, CYP2C19 ligands, study cytochrome P450 2C19 inhibitors, characterize cyp2c19 inhibitors, Cyt P450 inhibitor, Cyt P450 2C19 drug screening, Cytochrome P450 ligand screening kit, CypIIC19 ligand screening kit, CYP2C19 inhibitor screening, screen inhibitors of CYP enzymes, study cytochrome P450 inhibitors, characterize CYP inhibitors, Cytochrome P450 ligands, cytochrome P450 2C19, September-AK-15? Detection method - Fluorescence (Ex/Em 406/468 nm) ? Species reactivity - Eukaryotes ? Applications - ? Rapid, high-throughput screening of drugs and novel ligands. ? Development of structure-activity relationship (SAR) models to predict CYP2C19 inhibition liability of novel compounds. ? Prediction of adverse drug-drug interaction potential and bioavailability for compounds metabolized by CYP2C19.? Rapid, high-throughput screening of drugs and novel ligands. ? Development of structure-activity relationship (SAR) models to predict CYP2C19 inhibition liability of novel compounds. ? Prediction of adverse drug-drug interaction potential and bioavailability for compounds metabolized by CYP2C19.Samples containing drugs, inhibitors or ligands (compounds that can interact and affect CYP2C19 activity)